ETF Building Blocks Channel How Increased FDA Activity Can Benefit ETFs in Your Portfolio By Tom LydonNovember 19, 2020
ETF Building Blocks Channel A Healthcare ETF Review: Biotech Beckons under Biden By Tom LydonNovember 9, 2020
ETF Building Blocks Channel More than Just COVID: Hot ETFs for Medical Breakthroughs By Tom LydonNovember 5, 2020
ETF Building Blocks Channel For 2021 Upside, Bet on the SBIO Biotech ETF By Tom LydonOctober 29, 2020
ETF Building Blocks Channel Post-Election Considerations for a Nifty Biotech ETF By Tom LydonOctober 7, 2020
ETF Building Blocks Channel Election Impact Could Be Muted, Biotech Still Appealing By Todd ShriberSeptember 29, 2020
ETF Building Blocks Channel Acquisitions & Postive Drug Data Boost SBIO ETF Again By Special To VettaFiAugust 25, 2020
ETF Building Blocks Channel When Innovation and Being Nimble Matters, Turn to this Biotech ETF By Tom LydonAugust 3, 2020
ETF Building Blocks Channel Betting on Biotech With Utility Beyond Covid-19 By Tom LydonJuly 31, 2020
ETF Building Blocks Channel Fabulous Fundamentals Brighten Outlook for Healthcare, With This Biotech ETF By Tom LydonJuly 7, 2020
ETF Building Blocks Channel Another Round of Coronavirus Cases Puts This Biotech ETF in Focus By Tom LydonJune 29, 2020
ETF Building Blocks Channel A Healthcare ETF Could Benefit From Index Reshuffling By Tom LydonJune 23, 2020
ETF Building Blocks Channel Biotech ETFs in the Spotlight, Why They’ll Remain There By Tom LydonJune 18, 2020
ETF Building Blocks Channel Biotech ETF Doesn’t Need Coronavirus Vaccines to Soar By Tom LydonJune 2, 2020
